Triastek, Inc. is an international pharmaceutical company founded in July 2015 by Dr. Senping Cheng, who has entrepreneurial experience both in China and the United States, and Dr. Xiaoling Li, an American pharmaceutical scientist and educator. It is committed to building a novel 3D printing pharmaceutical technology platform for dosage form design, product development, and intelligent manufacturing. Triastek’s mission is to be a global leader in the field of 3D printing pharmaceuticals and establish a new era of intelligent pharmaceutical manufacturing.
Location: China
Employees: 51-200
Total raised: $70.4M
Founded date: 2015
Investors 2
| Date | Name | Website |
| - | triwise | en.triwise... |
| 09.02.2022 | Matrix Par... | matrixpart... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 09.10.2023 | - | $20.4M | - |
| 24.06.2021 | Series B | $50M | - |
Mentions in press and media 14
| Date | Title | Description |
| 04.12.2025 | Why Big Pharma Hasn’t Fully Adopted 3D Printing—Yet: Inside Triastek’s Push to Modernize Drug Manufacturing | In pharmaceutical manufacturing, tablets have long been produced through standardized processes that leave little room for fine-tuning how a drug behaves once ingested. Chinese pharmaceutical technology company Triastek is challenging that ... |
| 29.08.2025 | Battelle and Aprecia Partner with DARPA to Advance Agile Pharmaceutical Manufacturing | Private, nonprofit science and technology organization Battelle and 3D pharmaceutical company Aprecia have received a U.S. Defense Advanced Research Projects Agency (DARPA) agreement to advance the Establishing Qualification Processes for A... |
| 13.08.2025 | ETH Zurich Develops 3D Printed Heart Patch to Support Tissue Regeneration | A research team from the Swiss university ETH Zurich and the University Hospital of Zurich, led by Professors Robert Katzschmann and Omer Dzemali, has created a new 3D heart patch intended for implantation inside the heart. Published recent... |
| 30.06.2025 | 3D Systems and TISSIUM Receive FDA Approval for First-of-its-Kind Peripheral Nerve Repair Device | U.S.-based 3D printer manufacturer 3D Systems, in partnership with French MedTech firm TISSIUM, has secured FDA approval for a bioabsorbable, 3D printed device designed to treat peripheral nerve damage. This approval validates the polymer’s... |
| 25.03.2025 | FDA Grants IND Approval to Triastek’s 3D Printed Oral Anticoagulant T20G | Triastek, a Chinese 3D printing pharmaceutical company, has announced that its proprietary 3D printed non-vitamin K antagonist oral anticoagulant (NOAC), T20G, has received Investigational New Drug (IND) clearance from the U.S. Food and Dru... |
| 25.02.2025 | Triastek Advances 3D Printed D23 Budesonide Tablets for IgAN Treatment | Chinese drug 3D printing firm Triastek has announced that its 3D printed drug product, D23, Budesonide Ileum Targeted Tablets for the treatment of IgAN (Immunoglobulin A Nephropathy)—a kidney disorder characterized by the buildup of immunog... |
| 31.01.2024 | Triastek’s 3D Printed Gastric Retention Product T22 Receives FDA Clearance of IND Application | Triastek‘s 3D printed gastric retention product T22 received IND clearance from the FDA, becoming the world‘s first 3D printed gastric retention product. Currently, Triastek has four 3D printed products, T19, T20, T21, and T22, that have ob... |
| 09.10.2023 | Triastek Closes USD 20.4M Pre-C Funding Round | Triastek, a Nanjing, China-based company which specializes in 3D printing for pharmaceutical industry, raised USD 20.4M in Pre-C funding. The round was led by Guoxin Investment, with participation from Goldmine Multi-Family Office and exist... |
| 26.01.2023 | 3D Printing Industry News Sliced: 6K Additive, Axial3D, Lithoz, Wematter, Meltio, and more | In this edition of Sliced, the 3D Printing Industry news digest, we cover the latest business developments, partnerships, and acquisitions in the additive manufacturing sector. Today’s edition features new materials, partnerships, the acqui... |
| 24.07.2022 | Triastek and Eli Lilly partner to 3D print gastrointestinal drugs | Chinese drug 3D printing firm Triastek has announced a partnership with global pharmaceuticals company Eli Lilly to research and develop 3D printed oral drugs for the gastrointestinal tract. Specifically, the project will leverage Triastek’... |
Show more